Aikaterini Theodorou, Lina Palaiodimou, Apostolos Safouris, Odysseas Kargiotis, Klearchos Psychogios, Vasiliki Kotsali-Peteinelli, Aikaterini Foska, Vasiliki Zouvelou, Elias Tzavellas, Dimitrios Tzanetakos, Christina Zompola, John S Tzartos, Konstantinos Voumvourakis, Georgios P Paraskevas, Georgios Tsivgoulis
BACKGROUND: Limited data exist regarding the prevalence of clinical, neuroimaging, and genetic markers among patients diagnosed with Cerebral Amyloid Angiopathy-related inflammation (CAA-ri). We sought to determine these characteristics in patients diagnosed in our center and to summarize available literature published either as single-case reports or small case series (<5 patients). METHODS: We reported our single-center experience of patients diagnosed with CAA-ri according to international criteria during a seven-year period (2015-2022), and we abstracted data from 90 previously published cases...
November 14, 2022: Journal of Clinical Medicine